Insider · CIK 0001796398
Jay T. Backstrom
Files at AGIO (AGIOS PHARMACEUTICALS, INC.), SRRK (Scholar Rock Holding Corp), LVTX (LAVA Therapeutics NV). First filing Jan 21, 2025, latest Feb 20, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
SRRK: Scholar Rock Holding Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 53Moderate | Scholar Rock Holding Corp | $677k 18,372 shares | -6% | - | |
| 58Moderate | Scholar Rock Holding Corp | $986k 22,308 shares | -6% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Stock options (right to buy)derivative | +23,393 | $0.00 | $0 | 23,393 | Jul 10, 2025 |
| Jul 8, 2025 | AGIO AGIOS PHARMACEUTICALS, INC. | AGrant or award Restricted stock unitsderivative | +4,341 | $0.00 | $0 | 4,341 | Jul 10, 2025 |
| Mar 10, 2025 | SRRK Scholar Rock Holding Corp | AGrant or award Common Stock | +113,570 | $0.00 | $0 | 425,561 | Mar 12, 2025 |
| Mar 10, 2025 | SRRK Scholar Rock Holding Corp | AGrant or award Stock Option (Right to Buy)derivative | +151,430 | $0.00 | $0 | 151,430 | Mar 12, 2025 |
| Feb 18, 2025 | SRRK Scholar Rock Holding Corp | SOpen-market sale Common Stock | -18,372 | $36.83 | $677k | 311,991 | Feb 20, 2025 |
| Feb 13, 2025 | LVTX LAVA Therapeutics NV | AGrant or award Common Shares (Right to Buy)derivative | +33,390 | $0.00 | $0 | 33,390 | Feb 18, 2025 |
| Jan 16, 2025 | SRRK Scholar Rock Holding Corp | SOpen-market sale Common Stock | -22,308 | $44.20 | $986k | 330,363 | Jan 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.